US Bancorp DE Cuts Position in Surgery Partners, Inc. (NASDAQ:SGRY)

US Bancorp DE reduced its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 15.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,678 shares of the company’s stock after selling 506 shares during the quarter. US Bancorp DE’s holdings in Surgery Partners were worth $86,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Arizona State Retirement System raised its stake in shares of Surgery Partners by 1.9% during the second quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock valued at $464,000 after acquiring an additional 359 shares in the last quarter. Mackenzie Financial Corp lifted its holdings in shares of Surgery Partners by 3.4% in the 2nd quarter. Mackenzie Financial Corp now owns 19,999 shares of the company’s stock valued at $476,000 after buying an additional 662 shares during the period. ProShare Advisors LLC increased its holdings in shares of Surgery Partners by 7.8% during the 1st quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after purchasing an additional 986 shares in the last quarter. Natixis Advisors LLC increased its stake in shares of Surgery Partners by 11.0% in the 2nd quarter. Natixis Advisors LLC now owns 12,452 shares of the company’s stock valued at $296,000 after purchasing an additional 1,237 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale lifted its position in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter.

Surgery Partners Price Performance

SGRY stock opened at $22.95 on Friday. The company has a market capitalization of $2.92 billion, a PE ratio of -47.81, a P/E/G ratio of 18.74 and a beta of 2.76. The stock’s 50 day moving average is $30.62 and its two-hundred day moving average is $28.45. The company has a quick ratio of 1.69, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 52-week low of $22.25 and a 52-week high of $36.92.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to the consensus estimate of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.15 earnings per share. Analysts predict that Surgery Partners, Inc. will post 0.83 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. UBS Group assumed coverage on Surgery Partners in a research report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price on the stock. Citigroup lowered their target price on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th. KeyCorp started coverage on Surgery Partners in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. StockNews.com downgraded Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 target price on shares of Surgery Partners in a report on Friday, October 4th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $40.71.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.